These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

545 related articles for article (PubMed ID: 36822173)

  • 1. Mapping the interplay between NK cells and HIV: therapeutic implications.
    Anderko RR; Mailliard RB
    J Leukoc Biol; 2023 Feb; 113(2):109-138. PubMed ID: 36822173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early antiretroviral therapy and its impact on natural killer cell dynamics in HIV-1 infected men who have sex with men: a cross-sectional pilot study evaluating the impact of early ART initiation on NK cell perturbation in HIV infection.
    Akiso M; Muema D; Langat R; Naidoo KK; Oino G; Mutua G; Thobakgale C; Ochiel D; Chinyenze K; Anzala O; Mureithi MW
    Microbiol Spectr; 2024 Apr; 12(4):e0357023. PubMed ID: 38364104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Novel Toll-Like Receptor 9 Agonist, MGN1703, Enhances HIV-1 Transcription and NK Cell-Mediated Inhibition of HIV-1-Infected Autologous CD4+ T Cells.
    Offersen R; Nissen SK; Rasmussen TA; Østergaard L; Denton PW; Søgaard OS; Tolstrup M
    J Virol; 2016 May; 90(9):4441-4453. PubMed ID: 26889036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-15-Stimulated Natural Killer Cells Clear HIV-1-Infected Cells following Latency Reversal
    Garrido C; Abad-Fernandez M; Tuyishime M; Pollara JJ; Ferrari G; Soriano-Sarabia N; Margolis DM
    J Virol; 2018 Jun; 92(12):. PubMed ID: 29593039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TLR1/2 Agonist Enhances Reversal of HIV-1 Latency and Promotes NK Cell-Induced Suppression of HIV-1-Infected Autologous CD4
    Duan S; Xu X; Wang J; Huang L; Peng J; Yu T; Zhou Y; Cheng K; Liu S
    J Virol; 2021 Aug; 95(17):e0081621. PubMed ID: 34133900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The HIV Latency Reversal Agent HODHBt Enhances NK Cell Effector and Memory-Like Functions by Increasing Interleukin-15-Mediated STAT Activation.
    Macedo AB; Levinger C; Nguyen BN; Richard J; Gupta M; Cruz CRY; Finzi A; Chiappinelli KB; Crandall KA; Bosque A
    J Virol; 2022 Aug; 96(15):e0037222. PubMed ID: 35867565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanodepots Encapsulating a Latency Reversing Agent and Broadly Neutralizing Antibody Enhance Natural Killer Cell Cytotoxicity Against an in vitro Model of Latent HIV.
    Ghofrani J; Bowen A; Chen J; Balakrishnan PB; Powell AB; Cherukula K; Cruz CRY; Jones RB; Lynch RM; Sweeney EE; Fernandes R
    Int J Nanomedicine; 2023; 18():4055-4066. PubMed ID: 37520301
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Tomalka AG; Resto-Garay I; Campbell KS; Popkin DL
    Front Immunol; 2018; 9():2552. PubMed ID: 30455699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potent
    Bardhi A; Wu Y; Chen W; Li W; Zhu Z; Zheng JH; Wong H; Jeng E; Jones J; Ochsenbauer C; Kappes JC; Dimitrov DS; Ying T; Goldstein H
    J Virol; 2017 Oct; 91(20):. PubMed ID: 28794022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies and Antibody Derivatives: New Partners in HIV Eradication Strategies.
    Carrillo J; Clotet B; Blanco J
    Front Immunol; 2018; 9():2429. PubMed ID: 30405624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control of the HIV-1 DNA Reservoir Is Associated
    Marras F; Casabianca A; Bozzano F; Ascierto ML; Orlandi C; Di Biagio A; Pontali E; Dentone C; Orofino G; Nicolini L; Taramasso L; Magnani M; Marincola FM; Wang E; Moretta L; De Maria A
    J Virol; 2017 Dec; 91(23):. PubMed ID: 28956765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon Alpha Enhances NK Cell Function and the Suppressive Capacity of HIV-Specific CD8
    Kwaa AKR; Talana CAG; Blankson JN
    J Virol; 2019 Feb; 93(3):. PubMed ID: 30404799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NK cell-based therapies for HIV infection: Investigating current advances and future possibilities.
    Perera Molligoda Arachchige AS
    J Leukoc Biol; 2022 Apr; 111(4):921-931. PubMed ID: 34668588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Early Life Cytotoxic T Lymphocyte and Natural Killer Cell Immunity in Paediatric HIV Cure/Remission in the Anti-Retroviral Therapy Era.
    Vieira VA; Herbert N; Cromhout G; Adland E; Goulder P
    Front Immunol; 2022; 13():886562. PubMed ID: 35634290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deep Phenotypic Analysis of Blood and Lymphoid T and NK Cells From HIV+ Controllers and ART-Suppressed Individuals.
    George AF; Luo X; Neidleman J; Hoh R; Vohra P; Thomas R; Shin MG; Lee MJ; Blish CA; Deeks SG; Greene WC; Lee SA; Roan NR
    Front Immunol; 2022; 13():803417. PubMed ID: 35154118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chimeric Antigen Receptor T Cells Guided by the Single-Chain Fv of a Broadly Neutralizing Antibody Specifically and Effectively Eradicate Virus Reactivated from Latency in CD4+ T Lymphocytes Isolated from HIV-1-Infected Individuals Receiving Suppressive Combined Antiretroviral Therapy.
    Liu B; Zou F; Lu L; Chen C; He D; Zhang X; Tang X; Liu C; Li L; Zhang H
    J Virol; 2016 Nov; 90(21):9712-9724. PubMed ID: 27535056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of antiretroviral therapy in primary HIV infection on natural killer cell function and the association with viral rebound and HIV DNA following treatment interruption.
    Pace M; Ogbe A; Hurst J; Robinson N; Meyerowitz J; Olejniczak N; Thornhill JP; Jones M; Waters A; Lwanga J; Kuldanek K; Hall R; Zacharopoulou P; Martin GE; Brown H; Nwokolo N; Peppa D; Fox J; Fidler S; Frater J
    Front Immunol; 2022; 13():878743. PubMed ID: 36110857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune Checkpoint Blockade Restores HIV-Specific CD4 T Cell Help for NK Cells.
    Porichis F; Hart MG; Massa A; Everett HL; Morou A; Richard J; Brassard N; Veillette M; Hassan M; Ly NL; Routy JP; Freeman GJ; Dubé M; Finzi A; Kaufmann DE
    J Immunol; 2018 Aug; 201(3):971-981. PubMed ID: 29934472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The human IL-15 superagonist N-803 promotes migration of virus-specific CD8+ T and NK cells to B cell follicles but does not reverse latency in ART-suppressed, SHIV-infected macaques.
    Webb GM; Molden J; Busman-Sahay K; Abdulhaqq S; Wu HL; Weber WC; Bateman KB; Reed JS; Northrup M; Maier N; Tanaka S; Gao L; Davey B; Carpenter BL; Axthelm MK; Stanton JJ; Smedley J; Greene JM; Safrit JT; Estes JD; Skinner PJ; Sacha JB
    PLoS Pathog; 2020 Mar; 16(3):e1008339. PubMed ID: 32163523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Innate Immune Activity Correlates with CD4 T Cell-Associated HIV-1 DNA Decline during Latency-Reversing Treatment with Panobinostat.
    Olesen R; Vigano S; Rasmussen TA; Søgaard OS; Ouyang Z; Buzon M; Bashirova A; Carrington M; Palmer S; Brinkmann CR; Yu XG; Østergaard L; Tolstrup M; Lichterfeld M
    J Virol; 2015 Oct; 89(20):10176-89. PubMed ID: 26223643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.